Kurzporträt
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Disposable Blood Filters and Catheters
100,0
%
| 9 | 100,0 % | 9 | 100,0 % | +3.76% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 9 | 100,0 % | 9 | 100,0 % | +3.76% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Nestor Jaramillo
CEO | Chief Executive Officer | 66 | 07.05.19 |
Robert Scott
DFI | Director of Finance/CFO | 44 | 01.01.13 |
John Erb
CHM | Chairman | 75 | 01.09.12 |
John Jefferies
CTO | Chief Tech/Sci/R&D Officer | - | 05.01.23 |
Vitaliy Epshteyn
COO | Chief Operating Officer | 46 | 24.01.18 |
Neil Ayotte
CMP | Compliance Officer | 61 | 07.06.21 |
Laurent Duhoux
PRN | Corporate Officer/Principal | - | - |
Sandra Eayrs
HRO | Human Resources Officer | - | 01.01.14 |
John Kowalczyk
SAM | Sales & Marketing | - | 01.10.21 |
Paul Wotta
AUD | Comptroller/Controller/Auditor | 67 | 01.12.11 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
John Erb
CHM | Chairman | 75 | 01.09.12 |
Director/Board Member | 61 | 01.11. | |
Gregory Waller
BRD | Director/Board Member | 74 | 03.08.11 |
Nestor Jaramillo
CEO | Chief Executive Officer | 66 | 07.05.19 |
David McDonald
BRD | Director/Board Member | 63 | 01.11. |
Director/Board Member | 62 | 02.06.23 | |
Director/Board Member | 69 | 03.09.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 0 | 127 | 0 | 0 | 94,21 % |
Aktie B | 1 | 515 744 | 485 862 ( 94,21 %) | 0 |
Unternehmenskontakt
Nuwellis, Inc.
12988 Valley View Road
55344, Eden Prairie
+952 345 4200
http://www.nuwellis.com/patientsSektor
% 1. Jan. | Kap. | |
---|---|---|
+4.64% | 208 Mrd. | |
+8.99% | 182 Mrd. | |
+29.83% | 155 Mrd. | |
+35.17% | 115 Mrd. | |
+2.55% | 66.52 Mrd. | |
+15.06% | 53.93 Mrd. | |
-6.47% | 46.26 Mrd. | |
-2.14% | 38.22 Mrd. | |
+6.88% | 36.6 Mrd. |